Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

ISTH-BAT is predictive in hemophilia A and B

Borhany M et al. Transfus Apher Sci. 2018 Aug;57(4):556-60

Key clinical point: Bleeding score assessed with the ISTH-BAT may help identify or assess hemophilia patients, regardless of whether clotting factor levels are known.

Major finding: Bleeding scores were a mean of 13.5 and 13.2 for hemophilia A and B patients, respectively, and 0.8 for healthy male controls (P less than .001).

Study details: A cross-sectional study included 115 adult and pediatric patients with hemophilia A or B treated in Pakistan between 2014 and 2016.

Disclosures: The authors reported having no conflicts of interest.

Read the article here.


Borhany M et al. Transfus Apher Sci. 2018 Aug;57(4):556-60.